LeMaitre Vascular Q2 sales $42.1M (+8% organic); raises FY guidance to 10% organic growth

LEMAITRE VASCULAR INC

2022-Q2 EPS reported $0.43 revenue$81,669,000

Q2 2022 sales $42.1M (+4%, +8% organic); reported EPS $0.16 (-60%); adjusted EPS ex-special charge $0.29 (-26%).
Operating income $5.8M (-48%); ex-$3.1M special charge from closing St. Etienne factory, op income $8.9M (-20%).
FY 2022 guidance raised: sales $162.7M-$165.3M (mid $164M, +10% organic); op income ex-special $32.7M-$34.4M.
Board declared $0.125 quarterly dividend, payable Sept 8 to holders of record Aug 25; $20M share repurchase program ongoing.
Operational milestones: Seoul office opened, French factory closed, Chinese XenoSure cardiac approval filed, Omniflow II CE Mark received.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.